Protective Role of Carbon Monoxide in Hepatic I/R Injury
一氧化碳在肝缺血再灌注损伤中的保护作用
基本信息
- 批准号:8012885
- 负责人:
- 金额:$ 9.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-02-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAnti-Inflammatory AgentsAnti-inflammatoryAttentionBiologicalBiological PreservationBiological ProcessBlood CirculationBlood flowBreathingCarbon MonoxideCaringCell physiologyCellsCryopreservationCyclic GMPCytoprotectionDevelopmentDoseDown-RegulationEndothelial CellsEndothelinEnzymesFailureFamilyGoalsHemeHepaticHepatic Stellate CellHourImmunosuppressive AgentsIn VitroInflammatoryInflammatory ResponseInhalation TherapyInjuryIschemiaKupffer CellsLeadLiverMediatingMicrocirculationMitogen-Activated Protein KinasesMolecularMorbidity - disease rateOperative Surgical ProceduresOrganOrgan TransplantationOutcomeOxidantsOxygenasesPathway interactionsPatient CarePharmaceutical PreparationsPhysiologicalPopulationPostoperative CareProcessProtocols documentationRegulationReperfusion InjuryReperfusion TherapyResearch PersonnelRoleSeveritiesSignal PathwaySoluble Guanylate CyclaseSourceSystemTechniquesTissuesToxic effectTransplantationUp-RegulationVascular Endothelial Growth FactorsVascular resistanceadverse outcomebasecell injuryclinical applicationclinically relevantgraft functionheme oxygenase-1improvedin vivo Modelinnovationintrahepaticliver ischemialiver transplantationmortalityparacrineprogramsresearch studyresponsestellate cell
项目摘要
DESCRIPTION (provided by applicant): Advancements in immunosuppressive drugs, surgical techniques, and postoperative care have significantly improved outcomes of liver transplantation; however, cold preservation-associated ischemia/reperfusion (I/R) injury remains a major problem complicating posttransplant care and subsequent long-term transplant outcomes. Further, the recent organ shortage demands to expand the donor pool, and the use of liver grafts from marginal donors possibly augments I/R injury. Carbon monoxide (CO), an endogenous byproduct of heme, has lately received notable attention as a regulatory molecule in cellular and biological processes. During the last 3 years, we have evaluated the cytoprotective function of CO and obtained encouraging results showing that exogenous inhaled CO provides benefits against transplant-induced hepatic I/R injury. We hypothesize that CO protects liver grafts from hepatic I/R injury via the regulation of proinflammatory responses by directly inhibiting Kupffer cell activation and by improving sinusoidal circulation. We will pursue two specific aims to explore the clinical applicability, efficacy, and mechanisms of protection of low dose inhaled CO in ameliorating liver damage due to transplant preservation injury. AIM I: TO OPTIMIZE INHALED CO DELIVERY TO INHIBIT LIVER I/R INJURY. We will fully explore the regulatory effects of inhaled CO delivered in a clinically applicable manner to ameliorate hepatic I/R injury. Optimization of the delivery protocol will be established by administering CO as a brief inhalation therapy during the peritransplant period. To maximize CO efficacy, we will study effects obtained with donor and/or recipient treatment with CO. The potential adverse consequences of CO inhalation will also be investigated. AIM II: TO IDENTIFY THE MECHANISMS OF CO-MEDIATED PROTECTION OF LIVER GRAFTS. We will determine Kupffer cells as CO's direct target for antiproinflammatory function. Molecular mechanisms of CO- mediated antiinflammatory protection via the MAPK signaling pathways will be analyzed in isolated cell population. We will determine the mechanism of CO-mediated SEC protection and hepatic sinusoidal circulation via the inhibition of stellate cell activation and endothelin (ET) system. Our long-term goal in this proposal is to harness the benefit of CO pathway to improve early liver graft function and minimize the morbidity associated with severe preservation injury by fully exploring the regulatory mechanisms of CO.
描述(由申请人提供):免疫抑制药物、手术技术和术后护理的进步显著改善了肝移植的结局;然而,冷灌注相关的缺血/再灌注(I/R)损伤仍然是使移植后护理和随后的长期移植结局复杂化的主要问题。此外,最近的器官短缺要求扩大供体库,并且使用来自边缘供体的肝移植物可能增加I/R损伤。一氧化碳(CO)是血红素的内源性副产物,近年来作为细胞和生物过程的调节分子而受到关注。在过去的3年中,我们评估了CO的细胞保护功能,并获得了令人鼓舞的结果,表明外源性吸入CO对移植诱导的肝I/R损伤有益处。我们推测,CO通过直接抑制枯否细胞活化和改善肝窦循环来调节促炎反应,从而保护肝移植物免受肝I/R损伤。我们将追求两个具体的目标,以探讨临床适用性,有效性和低剂量吸入CO的保护机制,在改善由于移植保存损伤的肝损伤。目的I:优化吸入CO输送以抑制肝I/R损伤。我们将充分探讨临床上适用的方式提供吸入CO的调节作用,以改善肝脏I/R损伤。将通过在围移植期给予CO作为短暂吸入治疗来确定输送方案的优化。为了最大限度地提高一氧化碳的疗效,我们将研究供体和/或受体接受一氧化碳治疗的效果。还将研究吸入一氧化碳的潜在不良后果。目的II:确定肝移植物共介导保护的机制。我们将确定库普弗细胞作为CO抗炎功能的直接靶点。将在分离的细胞群中分析通过MAPK信号通路的CO介导的细胞保护的分子机制。我们将通过抑制星状细胞活化和内皮素(ET)系统来确定CO介导的SEC保护和肝窦循环的机制。本研究的长期目标是充分探索CO的调控机制,利用CO通路的益处改善早期移植肝功能,并将严重保存损伤相关的发病率降至最低。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hepatic B7 homolog 1 expression is essential for controlling cold ischemia/reperfusion injury after mouse liver transplantation.
- DOI:10.1002/hep.24360
- 发表时间:2011-07
- 期刊:
- 影响因子:13.5
- 作者:Ueki, Shinya;Castellaneta, Antonino;Yoshida, Osamu;Ozaki, Kikumi;Zhang, Matthew;Kimura, Shoko;Isse, Kumiko;Ross, Mark;Shao, Lifang;Stolz, Donna B.;Thomson, Angus W.;Demetris, Anthony J.;Geller, David A.;Murase, Noriko
- 通讯作者:Murase, Noriko
Ex vivo application of carbon monoxide in UW solution prevents transplant-induced renal ischemia/reperfusion injury in pigs.
- DOI:10.1111/j.1600-6143.2010.03040.x
- 发表时间:2010-04
- 期刊:
- 影响因子:0
- 作者:Yoshida J;Ozaki KS;Nalesnik MA;Ueki S;Castillo-Rama M;Faleo G;Ezzelarab M;Nakao A;Ekser B;Echeverri GJ;Ross MA;Stolz DB;Murase N
- 通讯作者:Murase N
Low-dose carbon monoxide inhibits progressive chronic allograft nephropathy and restores renal allograft function.
低剂量一氧化碳可抑制进行性慢性同种异体移植肾病并恢复同种异体移植肾功能。
- DOI:10.1152/ajprenal.90728.2008
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:Nakao,Atsunori;Faleo,Gaetano;Nalesnik,MichaelA;Seda-Neto,Joao;Kohmoto,Junichi;Murase,Noriko
- 通讯作者:Murase,Noriko
The loss of renal dendritic cells and activation of host adaptive immunity are long-term effects of ischemia/reperfusion injury following syngeneic kidney transplantation.
- DOI:10.1038/ki.2011.458
- 发表时间:2012-05
- 期刊:
- 影响因子:19.6
- 作者:
- 通讯作者:
Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation.
- DOI:10.1016/j.trre.2011.01.004
- 发表时间:2012-04
- 期刊:
- 影响因子:0
- 作者:Ozaki KS;Kimura S;Murase N
- 通讯作者:Murase N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NORIKO MURASE其他文献
NORIKO MURASE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NORIKO MURASE', 18)}}的其他基金
Protective Role of Carbon Monoxide in Hepatic I/R Injury
一氧化碳在肝缺血再灌注损伤中的保护作用
- 批准号:
7599536 - 财政年份:2007
- 资助金额:
$ 9.69万 - 项目类别:
Protective Role of Carbon Monoxide in Hepatic I/R Injury
一氧化碳在肝缺血再灌注损伤中的保护作用
- 批准号:
7404620 - 财政年份:2007
- 资助金额:
$ 9.69万 - 项目类别:
Protective Role of Carbon Monoxide in Hepatic I/R Injury
一氧化碳在肝缺血再灌注损伤中的保护作用
- 批准号:
7262376 - 财政年份:2007
- 资助金额:
$ 9.69万 - 项目类别:
MODULATION OF CHIMERISM FOR INTESTINAL TRANSPLANTATION
肠移植嵌合体的调节
- 批准号:
7349806 - 财政年份:2006
- 资助金额:
$ 9.69万 - 项目类别:
MODULATION OF CHIMERISM FOR INTESTINAL TRANSPLANTATION
肠移植嵌合体的调节
- 批准号:
7165360 - 财政年份:2005
- 资助金额:
$ 9.69万 - 项目类别:
MODULATION OF CHIMERISM FOR INTESTINAL TRANSPLANTATION
肠移植嵌合体的调节
- 批准号:
6971641 - 财政年份:2004
- 资助金额:
$ 9.69万 - 项目类别:
MODULATION OF CHIMERISM FOR INTESTINAL TRANSPLANTATION
肠移植嵌合体的调节
- 批准号:
6381189 - 财政年份:1999
- 资助金额:
$ 9.69万 - 项目类别:
MODULATION OF CHIMERISM FOR INTESTINAL TRANSPLANTATION
肠移植嵌合体的调节
- 批准号:
6517492 - 财政年份:1999
- 资助金额:
$ 9.69万 - 项目类别:
MODULATION OF CHIMERISM FOR INTESTINAL TRANSPLANTATION
肠移植嵌合体的调节
- 批准号:
2850515 - 财政年份:1999
- 资助金额:
$ 9.69万 - 项目类别:
MODULATION OF CHIMERISM FOR INTESTINAL TRANSPLANTATION
肠移植嵌合体的调节
- 批准号:
6178076 - 财政年份:1999
- 资助金额:
$ 9.69万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 9.69万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 9.69万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 9.69万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 9.69万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 9.69万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 9.69万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 9.69万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 9.69万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 9.69万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 9.69万 - 项目类别: